News stories about St Jude Medical (NYSE:STJ) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. St Jude Medical earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned media stories about the medical technology company an impact score of 46.6984266088036 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of St Jude Medical (STJ) opened at 80.82 on Tuesday. St Jude Medical has a 1-year low of $48.83 and a 1-year high of $84.00. The firm’s 50 day moving average is $79.81 and its 200-day moving average is $79.88.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/03/st-jude-medical-stj-receives-daily-media-sentiment-rating-of-0-13.html.

St Jude Medical Company Profile

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Insider Buying and Selling by Quarter for St Jude Medical (NYSE:STJ)

Receive News & Stock Ratings for St Jude Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical Inc and related stocks with our FREE daily email newsletter.